NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR - Currency: USD
CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older populations.
GSK's Blenrep approved in the U.K. for multiple myeloma after strong phase 3 data showing improved survival in DREAMM-7 and DREAMM-8 trials.
Gilead Sciences' leading HIV business might face a slowdown in 2025, even though a potential approval of lenacapavir would be a significant boost. We recommend investors to wait and watch for now.
Woodside Energy (WDS) said, “In response to recent media speculation, Woodside confirms it is in discussions with Uniper (UNPRF) regarding potential LNG supply. Discussions between the parties are ongoing and incomplete and no final agreement has been reached on the terms. Woodside will continue to update the market in accordance with its continuous disclosure obligations.” Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insider
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The U.S. CDC's Advisory Committee recommends the use of GSK and Pfizer's RSV vaccines in adults aged 50-59 who are at high risk of severe RSV disease.
The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent meningococcal vaccination schedule.
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the...
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS...
(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in its competing RSV shot Arexvy, according to a Thursday filing in Delaware federal court. GSK and Pfizer said in the filing that they would dismiss the case with prejudice, which means it cannot be refiled. GSK, Pfizer and Moderna have developed RSV shots approved by the U.S. Food and Drug Administration, with GSK's Arexvy responsible for the majority of U.S. RSV vaccine sales.
Mentions: PFE
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the...
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK)...
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS...
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are...
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the...
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK)...
(Reuters) -Elon Musk's xAI has acquired X in a deal that values the social media platform at $33 billion and allows the value of his artificial intelligence firm to be shared with his co-investors in the company formerly known as Twitter. The deal could also help xAI's ability to train its chatbot known as Grok. "xAI and X's futures are intertwined," Musk, who also heads automaker Tesla and SpaceX, wrote in a post on X: "Today, we officially take the step to combine the data, models, compute, distribution and talent."
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where PDD Holdings Inc. (NASDAQ:PDD) stands against the other ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Shell plc (NYSE:SHEL) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Trip.com Group Limited (NASDAQ:TCOM) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where HDFC Bank Limited (NYSE:HDB) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American […]
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS...
Electric car maker Tesla (NASDAQ: TSLA) has been under all sorts of pressure in 2025. Others are very concerned about first-quarter deliveries and how CEO Elon Musk's involvement in government affairs is affecting the company. Meanwhile, Chinese electric car maker BYD Company (OTC: BYDDY) just reported a huge quarter.